These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2146330)
1. Development of cytotoxic islet cell antibodies in rats following damage of the pancreas by complete Freund's adjuvant combined with a nondiabetogenic dose of streptozotocin. Kohnert KD; Ziegler B; Hehmke B; Fält K; Odselius R; Ziegler M Int J Pancreatol; 1990 Jan; 6(1):33-48. PubMed ID: 2146330 [TBL] [Abstract][Full Text] [Related]
2. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin. Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141 [TBL] [Abstract][Full Text] [Related]
3. Augmentation of streptozotocin-induced hyperglycemia in mice by prior treatment with complete Freund's adjuvant. Kohnert KD; Ziegler B; Fält K; Ziegler M Int J Pancreatol; 1989 Apr; 4(3):321-33. PubMed ID: 2527277 [TBL] [Abstract][Full Text] [Related]
4. Biochemical, immunohistochemical and ultrastructural studies of the alteration of pancreatic beta cells resulting from the combined effects of complete Freund's adjuvant and non-diabetogenic doses of streptozotocin. Kohnert KD; Ziegler B; Fält K; Odselius R; Ziegler M; Falkmer S Exp Clin Endocrinol; 1987 Aug; 89(3):259-68. PubMed ID: 2959491 [TBL] [Abstract][Full Text] [Related]
5. Histopathological lesions in the pancreas of a rat model of diabetes induced with complete Freund's adjuvant and low-dose streptozotocin. Kohnert KD; Fält K; Ziegler B; Odselius R; Ziegler M; Falkmer S Exp Clin Endocrinol; 1990 Feb; 95(1):47-56. PubMed ID: 2139852 [TBL] [Abstract][Full Text] [Related]
6. Genetic control of diabetes induction by complete Freund's adjuvant combined with subdiabetogenic doses of streptozotocin in Lewis rats--evidence for transient cytotoxicity against beta cells. Ziegler B; Tietz S; Kohnert KD; Köhler E; Knospe S; Klöting I; Ziegler M Exp Clin Endocrinol; 1987 Aug; 89(3):269-75. PubMed ID: 2959492 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of adjuvants, endotoxin, and fasting on induction of diabetes with multiple low doses of streptozocin in rats. Wright JR; Lacy PE Diabetes; 1988 Jan; 37(1):112-8. PubMed ID: 2961641 [TBL] [Abstract][Full Text] [Related]
8. Complete Freund's adjuvant has a differential amplification action on the induction of diabetes by streptozotocin in various murine strains: CFA amplifies STZ in murine diabetes. Richens ER; Tungekar MF; Behbehani K Pathology; 1987 Oct; 19(4):351-7. PubMed ID: 3328141 [TBL] [Abstract][Full Text] [Related]
9. Survival of islet isografts despite cytotoxicity against pancreatic islets measured in vitro. Ziegler B; Köhler E; Klöting I; Besch W; Ziegler M Exp Clin Endocrinol; 1990 Feb; 95(1):31-8. PubMed ID: 2139850 [TBL] [Abstract][Full Text] [Related]
10. Severe hyperglycaemia caused by autoimmunization to beta cells in rats. Ziegler M; Ziegler B; Hehmke B Diabetologia; 1984 Jul; 27 Suppl():163-5. PubMed ID: 6237014 [TBL] [Abstract][Full Text] [Related]
11. Silica prevents the induction of diabetes with complete Freund's adjuvant and low-dose streptozotocin in rats. Wright JR; Lacy PE Diabetes Res; 1989 Jun; 11(2):51-4. PubMed ID: 2559826 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune response directed to pancreatic beta cells in rats induced by combined treatment with low doses of streptozotocin and complete Freund's adjuvant. Ziegler M; Ziegler B; Hehmke B; Dietz H; Hildmann W; Kauert C Biomed Biochim Acta; 1984; 43(5):675-81. PubMed ID: 6236801 [TBL] [Abstract][Full Text] [Related]
13. Induction of islet cell surface and insulin antibodies in Balb/c mice by application of porcine insulin and Freund's adjuvant is not associated with insulitis. Augstein P; Kohnert KD; Ziegler B; Fürll B; Heinke P; Ziegler M Horm Metab Res; 1993 Jul; 25(7):344-7. PubMed ID: 8406317 [TBL] [Abstract][Full Text] [Related]
14. Islet beta-cytotoxic monoclonal antibody against glycolipids in experimental diabetes induced by low dose streptozotocin and Freund's adjuvant. Ziegler M; Teneberg S; Witt S; Ziegler B; Hehmke B; Kohnert KD; Egeberg J; Karlsson KA; Lernmark A J Immunol; 1988 Jun; 140(12):4144-50. PubMed ID: 2967328 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of monoclonal antibodies against pancreatic beta cells. Ziegler B; Witt S; Waterstradt B; Schlosser M; Ziegler M Exp Clin Endocrinol; 1989 May; 93(2-3):173-80. PubMed ID: 2673811 [TBL] [Abstract][Full Text] [Related]
16. Generation and partial characterization of monoclonal antibodies reactive with islet cell antigens. Witt S; Ziegler B; Waterstradt B; Besch W; Hehmke B; Ziegler M Exp Clin Endocrinol; 1987 Aug; 89(3):276-82. PubMed ID: 3311774 [TBL] [Abstract][Full Text] [Related]
17. Detection of antibodies to islet cell and splenic lymphocytes in diabetes-prone BB and adjuvant-streptozotocin treated Lewis rats by ELISA and immunoblot analysis. Kohnert KD; Besch W; Schröder D; Ziegler B; Hehmke B; Fält K; Ziegler M Allerg Immunol (Leipz); 1990; 36(4):321-31. PubMed ID: 2097900 [TBL] [Abstract][Full Text] [Related]
18. A longitudinal ultrastructural study of pancreatic cellular damage in murine streptozotocin diabetes. Richens ER; Tungekar FM; Behbehani K Acta Diabetol Lat; 1988; 25(3):185-95. PubMed ID: 3071064 [TBL] [Abstract][Full Text] [Related]
19. Genetic control of susceptibility to severe hyperglycaemia evoked by CFA/SZ-induced immune response against beta cells in various rat strains. Ziegler M; Ziegler B; Kohnert KD; Klöting I Biomed Biochim Acta; 1988; 47(4-5):337-42. PubMed ID: 2977097 [TBL] [Abstract][Full Text] [Related]